Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies
Molecular Cancer volume 18, Article number: 79 (2019)
Correction to: Mol Cancer
Following publication of the original article , the authors reported an error in Table 1. Incorrect value was placed under Efficacy (column), R/R non-GCB DLBCL (row).The value 92% was captured instead of 35%. Corrected table is shown below. The authors would like to apologize for this error.
Singh PS, Dammeijer F, Hendriks RW. Role of Bruton’s tyrosine kinase in B cellsand malignancies. Mol Cancer. 2018;17:57 https://doi.org/10.1186/s12943-018-0779-z.
About this article
Cite this article
Pal Singh, S., Dammeijer, F. & Hendriks, R.W. Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies. Mol Cancer 18, 79 (2019). https://doi.org/10.1186/s12943-019-1009-z